Citizens Business Bank Biogen Inc. Transaction History

Citizens Business Bank

  • $466 Million
  • Q1 2024

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Nov 18, 2022
SELL
$258.66 - $342.55 $1.2 Million - $1.6 Million
-4,657 Closed
0 $0
Q1 2020

Nov 18, 2022
SELL
$268.85 - $341.04 $77,428 - $98,219
-288 Reduced 5.82%
4,657 $1.47 Million
Q4 2019

Nov 18, 2022
SELL
$220.06 - $304.07 $21,125 - $29,190
-96 Reduced 1.9%
4,945 $1.47 Million
Q3 2019

Nov 18, 2022
SELL
$217.44 - $243.88 $13,916 - $15,608
-64 Reduced 1.25%
5,041 $1.17 Million
Q2 2019

Nov 18, 2022
SELL
$219.29 - $241.72 $18,420 - $20,304
-84 Reduced 1.62%
5,105 $1.19 Million
Q1 2019

Nov 18, 2022
SELL
$216.71 - $338.96 $18,203 - $28,472
-84 Reduced 1.59%
5,189 $1.23 Million
Q4 2018

Nov 18, 2022
SELL
$278.5 - $352.75 $44,560 - $56,440
-160 Reduced 2.94%
5,273 $1.59 Million
Q3 2018

Nov 18, 2022
SELL
$293.51 - $383.83 $31,699 - $41,453
-108 Reduced 1.95%
5,433 $1.92 Million
Q2 2018

Nov 18, 2022
SELL
$257.52 - $306.91 $1.37 Million - $1.63 Million
-5,307 Reduced 48.92%
5,541 $1.61 Million
Q1 2018

Nov 18, 2022
SELL
$260.13 - $367.91 $49,164 - $69,534
-189 Reduced 1.71%
10,848 $2.97 Million
Q4 2017

Nov 18, 2022
SELL
$307.64 - $344.58 $81,524 - $91,313
-265 Reduced 2.34%
11,037 $3.52 Million
Q3 2017

Nov 18, 2022
SELL
$281.15 - $329.69 $81,814 - $95,939
-291 Reduced 2.51%
11,302 $3.54 Million
Q2 2017

Nov 18, 2022
BUY
N/A
11,593 New
11,593 $3.15 Million
Q1 2017

Nov 18, 2022
BUY
N/A
89 Added 1.17%
7,698 $2.11 Million
Q4 2016

Nov 18, 2022
SELL
N/A
-2,639 Reduced 25.75%
7,609 $2.16 Million
Q3 2016

Nov 18, 2022
SELL
N/A
-1,013 Reduced 9.0%
10,248 $3.21 Million
Q2 2016

Nov 18, 2022
BUY
N/A
3,808 Added 51.09%
11,261 $2.72 Million
Q1 2016

Nov 18, 2022
SELL
N/A
-165 Reduced 2.17%
7,453 $1.94 Million
Q4 2015

Nov 18, 2022
SELL
N/A
-913 Reduced 10.7%
7,618 $2.33 Million
Q3 2015

Nov 18, 2022
BUY
N/A
139 Added 1.66%
8,531 $2.49 Million
Q2 2015

Nov 18, 2022
BUY
N/A
229 Added 2.81%
8,392 $3.39 Million
Q1 2015

Nov 18, 2022
BUY
N/A
8,163
8,163 $3.45 Million

Others Institutions Holding BIIB

# of Institutions
1,047
Shares Held
126M
Call Options Held
1.37M
Put Options Held
1.35M
View Full List

About BIOGEN INC.

BIIB Quotes by TradingView
  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $33B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Citizens Business Bank Portfolio

Follow Citizens Business Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citizens Business Bank, based on Form 13F filings with the SEC.

News

Stay updated on Citizens Business Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email